Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation

Depleting the microenvironment of important nutrients such as arginine is a key strategy for immune evasion by cancer cells. Many tumors overexpress arginase, but it is unclear how these cancers, but not T cells, tolerate arginine depletion. In this study, we show that tumor cells synthesize arginin...

Full description

Bibliographic Details
Main Authors: Crump, NT, Hadjinicolaou, AV, Xia, M, Walsby-Tickle, J, Gileadi, U, Chen, J-L, Setshedi, M, Olsen, LR, Lau, I-J, Godfrey, L, Quek, L, Yu, Z, Ballabio, E, Barnkob, MB, Napolitani, G, Salio, M, Koohy, H, Kessler, BM, Taylor, S, Vyas, P, McCullagh, JSO, Milne, TA, Cerundolo, V
Format: Journal article
Language:English
Published: Cell Press 2021
Description
Summary:Depleting the microenvironment of important nutrients such as arginine is a key strategy for immune evasion by cancer cells. Many tumors overexpress arginase, but it is unclear how these cancers, but not T cells, tolerate arginine depletion. In this study, we show that tumor cells synthesize arginine from citrulline by upregulating argininosuccinate synthetase 1 (ASS1). Under arginine starvation, ASS1 transcription is induced by ATF4 and CEBPβ binding to an enhancer within ASS1. T cells cannot induce ASS1, despite the presence of active ATF4 and CEBPβ, as the gene is repressed. Arginine starvation drives global chromatin compaction and repressive histone methylation, which disrupts ATF4/CEBPβ binding and target gene transcription. We find that T cell activation is impaired in arginine-depleted conditions, with significant metabolic perturbation linked to incomplete chromatin remodeling and misregulation of key genes. Our results highlight a T cell behavior mediated by nutritional stress, exploited by cancer cells to enable pathological immune evasion.